Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Oncology Institute Inc - SIC # 8011 - OFFICES AND CLINICS OF DOCTORS OF MEDICINE
Ticker
Exchange
SIC #
Website
Latest Ticker
TOI
Nasdaq
8011
https://theoncologyinstitute.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Oncology Institute Inc
The Oncology Institute Expands Into Chino, CA
- Dec 19th, 2022 1:00 pm
The Oncology Institute Rebrands Clinical Trials Division
- Dec 15th, 2022 1:00 pm
The Oncology Institute Expands into Miami-Dade County, Hires National Oncology Leader Dr. Roberto Ochoa
- Nov 22nd, 2022 1:00 pm
The Oncology Institute Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Guidance
- Nov 9th, 2022 9:05 pm
The Oncology Institute to Participate at the Credit Suisse 31st Annual Healthcare Conference
- Nov 1st, 2022 12:00 pm
The Oncology Institute Announces Third Quarter 2022 Earnings Release Date and Conference Call
- Oct 19th, 2022 12:00 pm
The Oncology Institute Executives to Speak at Key Industry Conferences in Q4
- Oct 17th, 2022 8:05 pm
The Oncology Institute Announces New Leaders to Oversee Technology and Clinical Trials
- Oct 11th, 2022 12:00 pm
The Oncology Institute Expands into South Florida
- Oct 6th, 2022 12:00 pm
The Oncology Institute Enrolls Nation’s First Two Patients in a Phase 3 Open-Label, Randomized Clinical Trial of Pirtobrutinib
- Sep 29th, 2022 12:00 pm
The Oncology Institute Appoints Two New Board Members
- Sep 22nd, 2022 8:05 pm
The Oncology Institute to Participate at the Nephron 2nd Annual Physician Enablement Symposium
- Sep 15th, 2022 12:00 pm
The Oncology Institute Becomes Certified as a Patient Safety Organization
- Sep 12th, 2022 12:00 pm
The Oncology Institute Partners with Blue Note Therapeutics to Provide a Digital Therapeutic for Treating Cancer-related Anxiety and Depression Symptoms
- Aug 22nd, 2022 12:00 pm
The Oncology Institute to Participate at the Baird Newly Public Company Virtual Access Day
- Aug 16th, 2022 12:00 pm
The Oncology Institute Reports Second Quarter 2022 Financial Results and Reaffirms Full Year 2022 Guidance
- Aug 9th, 2022 8:06 pm
The Oncology Institute announces $110 million strategic investment by Deerfield Management to accelerate its expansion into new markets
- Aug 9th, 2022 8:05 pm
The Oncology Institute Continues its Nevada Expansion
- Jul 26th, 2022 12:00 pm
The Oncology Institute Announces Second Quarter 2022 Earnings Release Date and Conference Call
- Jul 19th, 2022 12:00 pm
The Oncology Institute Continues Southern California Expansion
- Jul 7th, 2022 8:05 pm
Scroll